Medical Care
Global CRISPR Nucleases Market Research Report 2025
- May 05, 25
- ID: 228202
- Pages: 89
- Figures: 81
- Views: 2
The global market for CRISPR Nucleases was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CRISPR Nucleases in Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CRISPR Nucleases include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Nucleases.
The CRISPR Nucleases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Nucleases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
TriLink BioTechnologies
Qiagen
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Horizon Discovery Plc
Sigma Aldrich
Genscript
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Aldevron
Takara Bio
Segment by Type
CRISPR Cas3
CRISPR Cas9
CRISPR Cas10
Others
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Nucleases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CRISPR Nucleases is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CRISPR Nucleases in Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CRISPR Nucleases include Thermo Fisher, TriLink BioTechnologies, Qiagen, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Horizon Discovery Plc, Sigma Aldrich, Genscript, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPR Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Nucleases.
The CRISPR Nucleases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR Nucleases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
TriLink BioTechnologies
Qiagen
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Horizon Discovery Plc
Sigma Aldrich
Genscript
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Aldevron
Takara Bio
Segment by Type
CRISPR Cas3
CRISPR Cas9
CRISPR Cas10
Others
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Nucleases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Nucleases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRISPR Cas3
1.2.3 CRISPR Cas9
1.2.4 CRISPR Cas10
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Nucleases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Nucleases Market Perspective (2020-2031)
2.2 Global CRISPR Nucleases Growth Trends by Region
2.2.1 Global CRISPR Nucleases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR Nucleases Historic Market Size by Region (2020-2025)
2.2.3 CRISPR Nucleases Forecasted Market Size by Region (2026-2031)
2.3 CRISPR Nucleases Market Dynamics
2.3.1 CRISPR Nucleases Industry Trends
2.3.2 CRISPR Nucleases Market Drivers
2.3.3 CRISPR Nucleases Market Challenges
2.3.4 CRISPR Nucleases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Nucleases Players by Revenue
3.1.1 Global Top CRISPR Nucleases Players by Revenue (2020-2025)
3.1.2 Global CRISPR Nucleases Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR Nucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR Nucleases Revenue
3.4 Global CRISPR Nucleases Market Concentration Ratio
3.4.1 Global CRISPR Nucleases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Nucleases Revenue in 2024
3.5 Global Key Players of CRISPR Nucleases Head office and Area Served
3.6 Global Key Players of CRISPR Nucleases, Product and Application
3.7 Global Key Players of CRISPR Nucleases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Nucleases Breakdown Data by Type
4.1 Global CRISPR Nucleases Historic Market Size by Type (2020-2025)
4.2 Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031)
5 CRISPR Nucleases Breakdown Data by Application
5.1 Global CRISPR Nucleases Historic Market Size by Application (2020-2025)
5.2 Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR Nucleases Market Size (2020-2031)
6.2 North America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR Nucleases Market Size by Country (2020-2025)
6.4 North America CRISPR Nucleases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Nucleases Market Size (2020-2031)
7.2 Europe CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR Nucleases Market Size by Country (2020-2025)
7.4 Europe CRISPR Nucleases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Nucleases Market Size (2020-2031)
8.2 Asia-Pacific CRISPR Nucleases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Nucleases Market Size (2020-2031)
9.2 Latin America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR Nucleases Market Size by Country (2020-2025)
9.4 Latin America CRISPR Nucleases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Nucleases Market Size (2020-2031)
10.2 Middle East & Africa CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher CRISPR Nucleases Introduction
11.1.4 Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 TriLink BioTechnologies
11.2.1 TriLink BioTechnologies Company Details
11.2.2 TriLink BioTechnologies Business Overview
11.2.3 TriLink BioTechnologies CRISPR Nucleases Introduction
11.2.4 TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025)
11.2.5 TriLink BioTechnologies Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen CRISPR Nucleases Introduction
11.3.4 Qiagen Revenue in CRISPR Nucleases Business (2020-2025)
11.3.5 Qiagen Recent Development
11.4 Editas Medicine
11.4.1 Editas Medicine Company Details
11.4.2 Editas Medicine Business Overview
11.4.3 Editas Medicine CRISPR Nucleases Introduction
11.4.4 Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025)
11.4.5 Editas Medicine Recent Development
11.5 Caribou Biosciences
11.5.1 Caribou Biosciences Company Details
11.5.2 Caribou Biosciences Business Overview
11.5.3 Caribou Biosciences CRISPR Nucleases Introduction
11.5.4 Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025)
11.5.5 Caribou Biosciences Recent Development
11.6 CRISPR therapeutics
11.6.1 CRISPR therapeutics Company Details
11.6.2 CRISPR therapeutics Business Overview
11.6.3 CRISPR therapeutics CRISPR Nucleases Introduction
11.6.4 CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025)
11.6.5 CRISPR therapeutics Recent Development
11.7 Intellia therapeutics, Inc.
11.7.1 Intellia therapeutics, Inc. Company Details
11.7.2 Intellia therapeutics, Inc. Business Overview
11.7.3 Intellia therapeutics, Inc. CRISPR Nucleases Introduction
11.7.4 Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025)
11.7.5 Intellia therapeutics, Inc. Recent Development
11.8 Horizon Discovery Plc
11.8.1 Horizon Discovery Plc Company Details
11.8.2 Horizon Discovery Plc Business Overview
11.8.3 Horizon Discovery Plc CRISPR Nucleases Introduction
11.8.4 Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025)
11.8.5 Horizon Discovery Plc Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich CRISPR Nucleases Introduction
11.9.4 Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025)
11.9.5 Sigma Aldrich Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR Nucleases Introduction
11.10.4 Genscript Revenue in CRISPR Nucleases Business (2020-2025)
11.10.5 Genscript Recent Development
11.11 Integrated DNA Technologies
11.11.1 Integrated DNA Technologies Company Details
11.11.2 Integrated DNA Technologies Business Overview
11.11.3 Integrated DNA Technologies CRISPR Nucleases Introduction
11.11.4 Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025)
11.11.5 Integrated DNA Technologies Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Details
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs CRISPR Nucleases Introduction
11.12.4 New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025)
11.12.5 New England Biolabs Recent Development
11.13 Origene Technologies
11.13.1 Origene Technologies Company Details
11.13.2 Origene Technologies Business Overview
11.13.3 Origene Technologies CRISPR Nucleases Introduction
11.13.4 Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025)
11.13.5 Origene Technologies Recent Development
11.14 Aldevron
11.14.1 Aldevron Company Details
11.14.2 Aldevron Business Overview
11.14.3 Aldevron CRISPR Nucleases Introduction
11.14.4 Aldevron Revenue in CRISPR Nucleases Business (2020-2025)
11.14.5 Aldevron Recent Development
11.15 Takara Bio
11.15.1 Takara Bio Company Details
11.15.2 Takara Bio Business Overview
11.15.3 Takara Bio CRISPR Nucleases Introduction
11.15.4 Takara Bio Revenue in CRISPR Nucleases Business (2020-2025)
11.15.5 Takara Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR Nucleases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CRISPR Cas3
1.2.3 CRISPR Cas9
1.2.4 CRISPR Cas10
1.2.5 Others
1.3 Market by Application
1.3.1 Global CRISPR Nucleases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR Nucleases Market Perspective (2020-2031)
2.2 Global CRISPR Nucleases Growth Trends by Region
2.2.1 Global CRISPR Nucleases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR Nucleases Historic Market Size by Region (2020-2025)
2.2.3 CRISPR Nucleases Forecasted Market Size by Region (2026-2031)
2.3 CRISPR Nucleases Market Dynamics
2.3.1 CRISPR Nucleases Industry Trends
2.3.2 CRISPR Nucleases Market Drivers
2.3.3 CRISPR Nucleases Market Challenges
2.3.4 CRISPR Nucleases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR Nucleases Players by Revenue
3.1.1 Global Top CRISPR Nucleases Players by Revenue (2020-2025)
3.1.2 Global CRISPR Nucleases Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR Nucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR Nucleases Revenue
3.4 Global CRISPR Nucleases Market Concentration Ratio
3.4.1 Global CRISPR Nucleases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR Nucleases Revenue in 2024
3.5 Global Key Players of CRISPR Nucleases Head office and Area Served
3.6 Global Key Players of CRISPR Nucleases, Product and Application
3.7 Global Key Players of CRISPR Nucleases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR Nucleases Breakdown Data by Type
4.1 Global CRISPR Nucleases Historic Market Size by Type (2020-2025)
4.2 Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031)
5 CRISPR Nucleases Breakdown Data by Application
5.1 Global CRISPR Nucleases Historic Market Size by Application (2020-2025)
5.2 Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR Nucleases Market Size (2020-2031)
6.2 North America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR Nucleases Market Size by Country (2020-2025)
6.4 North America CRISPR Nucleases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR Nucleases Market Size (2020-2031)
7.2 Europe CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR Nucleases Market Size by Country (2020-2025)
7.4 Europe CRISPR Nucleases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR Nucleases Market Size (2020-2031)
8.2 Asia-Pacific CRISPR Nucleases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR Nucleases Market Size (2020-2031)
9.2 Latin America CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR Nucleases Market Size by Country (2020-2025)
9.4 Latin America CRISPR Nucleases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR Nucleases Market Size (2020-2031)
10.2 Middle East & Africa CRISPR Nucleases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher CRISPR Nucleases Introduction
11.1.4 Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 TriLink BioTechnologies
11.2.1 TriLink BioTechnologies Company Details
11.2.2 TriLink BioTechnologies Business Overview
11.2.3 TriLink BioTechnologies CRISPR Nucleases Introduction
11.2.4 TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025)
11.2.5 TriLink BioTechnologies Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen CRISPR Nucleases Introduction
11.3.4 Qiagen Revenue in CRISPR Nucleases Business (2020-2025)
11.3.5 Qiagen Recent Development
11.4 Editas Medicine
11.4.1 Editas Medicine Company Details
11.4.2 Editas Medicine Business Overview
11.4.3 Editas Medicine CRISPR Nucleases Introduction
11.4.4 Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025)
11.4.5 Editas Medicine Recent Development
11.5 Caribou Biosciences
11.5.1 Caribou Biosciences Company Details
11.5.2 Caribou Biosciences Business Overview
11.5.3 Caribou Biosciences CRISPR Nucleases Introduction
11.5.4 Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025)
11.5.5 Caribou Biosciences Recent Development
11.6 CRISPR therapeutics
11.6.1 CRISPR therapeutics Company Details
11.6.2 CRISPR therapeutics Business Overview
11.6.3 CRISPR therapeutics CRISPR Nucleases Introduction
11.6.4 CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025)
11.6.5 CRISPR therapeutics Recent Development
11.7 Intellia therapeutics, Inc.
11.7.1 Intellia therapeutics, Inc. Company Details
11.7.2 Intellia therapeutics, Inc. Business Overview
11.7.3 Intellia therapeutics, Inc. CRISPR Nucleases Introduction
11.7.4 Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025)
11.7.5 Intellia therapeutics, Inc. Recent Development
11.8 Horizon Discovery Plc
11.8.1 Horizon Discovery Plc Company Details
11.8.2 Horizon Discovery Plc Business Overview
11.8.3 Horizon Discovery Plc CRISPR Nucleases Introduction
11.8.4 Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025)
11.8.5 Horizon Discovery Plc Recent Development
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich CRISPR Nucleases Introduction
11.9.4 Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025)
11.9.5 Sigma Aldrich Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR Nucleases Introduction
11.10.4 Genscript Revenue in CRISPR Nucleases Business (2020-2025)
11.10.5 Genscript Recent Development
11.11 Integrated DNA Technologies
11.11.1 Integrated DNA Technologies Company Details
11.11.2 Integrated DNA Technologies Business Overview
11.11.3 Integrated DNA Technologies CRISPR Nucleases Introduction
11.11.4 Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025)
11.11.5 Integrated DNA Technologies Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Details
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs CRISPR Nucleases Introduction
11.12.4 New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025)
11.12.5 New England Biolabs Recent Development
11.13 Origene Technologies
11.13.1 Origene Technologies Company Details
11.13.2 Origene Technologies Business Overview
11.13.3 Origene Technologies CRISPR Nucleases Introduction
11.13.4 Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025)
11.13.5 Origene Technologies Recent Development
11.14 Aldevron
11.14.1 Aldevron Company Details
11.14.2 Aldevron Business Overview
11.14.3 Aldevron CRISPR Nucleases Introduction
11.14.4 Aldevron Revenue in CRISPR Nucleases Business (2020-2025)
11.14.5 Aldevron Recent Development
11.15 Takara Bio
11.15.1 Takara Bio Company Details
11.15.2 Takara Bio Business Overview
11.15.3 Takara Bio CRISPR Nucleases Introduction
11.15.4 Takara Bio Revenue in CRISPR Nucleases Business (2020-2025)
11.15.5 Takara Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR Nucleases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRISPR Cas3
Table 3. Key Players of CRISPR Cas9
Table 4. Key Players of CRISPR Cas10
Table 5. Key Players of Others
Table 6. Global CRISPR Nucleases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CRISPR Nucleases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CRISPR Nucleases Market Share by Region (2020-2025)
Table 10. Global CRISPR Nucleases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CRISPR Nucleases Market Share by Region (2026-2031)
Table 12. CRISPR Nucleases Market Trends
Table 13. CRISPR Nucleases Market Drivers
Table 14. CRISPR Nucleases Market Challenges
Table 15. CRISPR Nucleases Market Restraints
Table 16. Global CRISPR Nucleases Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CRISPR Nucleases Market Share by Players (2020-2025)
Table 18. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)
Table 19. Ranking of Global Top CRISPR Nucleases Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CRISPR Nucleases Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CRISPR Nucleases, Headquarters and Area Served
Table 22. Global Key Players of CRISPR Nucleases, Product and Application
Table 23. Global Key Players of CRISPR Nucleases, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Nucleases Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CRISPR Nucleases Revenue Market Share by Type (2020-2025)
Table 27. Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CRISPR Nucleases Revenue Market Share by Type (2026-2031)
Table 29. Global CRISPR Nucleases Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CRISPR Nucleases Revenue Market Share by Application (2020-2025)
Table 31. Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CRISPR Nucleases Revenue Market Share by Application (2026-2031)
Table 33. North America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CRISPR Nucleases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Company Details
Table 49. Thermo Fisher Business Overview
Table 50. Thermo Fisher CRISPR Nucleases Product
Table 51. Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Recent Development
Table 53. TriLink BioTechnologies Company Details
Table 54. TriLink BioTechnologies Business Overview
Table 55. TriLink BioTechnologies CRISPR Nucleases Product
Table 56. TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 57. TriLink BioTechnologies Recent Development
Table 58. Qiagen Company Details
Table 59. Qiagen Business Overview
Table 60. Qiagen CRISPR Nucleases Product
Table 61. Qiagen Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 62. Qiagen Recent Development
Table 63. Editas Medicine Company Details
Table 64. Editas Medicine Business Overview
Table 65. Editas Medicine CRISPR Nucleases Product
Table 66. Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 67. Editas Medicine Recent Development
Table 68. Caribou Biosciences Company Details
Table 69. Caribou Biosciences Business Overview
Table 70. Caribou Biosciences CRISPR Nucleases Product
Table 71. Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 72. Caribou Biosciences Recent Development
Table 73. CRISPR therapeutics Company Details
Table 74. CRISPR therapeutics Business Overview
Table 75. CRISPR therapeutics CRISPR Nucleases Product
Table 76. CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 77. CRISPR therapeutics Recent Development
Table 78. Intellia therapeutics, Inc. Company Details
Table 79. Intellia therapeutics, Inc. Business Overview
Table 80. Intellia therapeutics, Inc. CRISPR Nucleases Product
Table 81. Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 82. Intellia therapeutics, Inc. Recent Development
Table 83. Horizon Discovery Plc Company Details
Table 84. Horizon Discovery Plc Business Overview
Table 85. Horizon Discovery Plc CRISPR Nucleases Product
Table 86. Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 87. Horizon Discovery Plc Recent Development
Table 88. Sigma Aldrich Company Details
Table 89. Sigma Aldrich Business Overview
Table 90. Sigma Aldrich CRISPR Nucleases Product
Table 91. Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 92. Sigma Aldrich Recent Development
Table 93. Genscript Company Details
Table 94. Genscript Business Overview
Table 95. Genscript CRISPR Nucleases Product
Table 96. Genscript Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 97. Genscript Recent Development
Table 98. Integrated DNA Technologies Company Details
Table 99. Integrated DNA Technologies Business Overview
Table 100. Integrated DNA Technologies CRISPR Nucleases Product
Table 101. Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 102. Integrated DNA Technologies Recent Development
Table 103. New England Biolabs Company Details
Table 104. New England Biolabs Business Overview
Table 105. New England Biolabs CRISPR Nucleases Product
Table 106. New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 107. New England Biolabs Recent Development
Table 108. Origene Technologies Company Details
Table 109. Origene Technologies Business Overview
Table 110. Origene Technologies CRISPR Nucleases Product
Table 111. Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 112. Origene Technologies Recent Development
Table 113. Aldevron Company Details
Table 114. Aldevron Business Overview
Table 115. Aldevron CRISPR Nucleases Product
Table 116. Aldevron Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 117. Aldevron Recent Development
Table 118. Takara Bio Company Details
Table 119. Takara Bio Business Overview
Table 120. Takara Bio CRISPR Nucleases Product
Table 121. Takara Bio Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 122. Takara Bio Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. CRISPR Nucleases Picture
Figure 2. Global CRISPR Nucleases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR Nucleases Market Share by Type: 2024 VS 2031
Figure 4. CRISPR Cas3 Features
Figure 5. CRISPR Cas9 Features
Figure 6. CRISPR Cas10 Features
Figure 7. Others Features
Figure 8. Global CRISPR Nucleases Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CRISPR Nucleases Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR Nucleases Report Years Considered
Figure 15. Global CRISPR Nucleases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CRISPR Nucleases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CRISPR Nucleases Market Share by Region: 2024 VS 2031
Figure 18. Global CRISPR Nucleases Market Share by Players in 2024
Figure 19. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CRISPR Nucleases Revenue in 2024
Figure 21. North America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CRISPR Nucleases Market Share by Country (2020-2031)
Figure 23. United States CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CRISPR Nucleases Market Share by Country (2020-2031)
Figure 27. Germany CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CRISPR Nucleases Market Share by Region (2020-2031)
Figure 35. China CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CRISPR Nucleases Market Share by Country (2020-2031)
Figure 43. Mexico CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CRISPR Nucleases Market Share by Country (2020-2031)
Figure 47. Turkey CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 51. TriLink BioTechnologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 52. Qiagen Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 53. Editas Medicine Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 54. Caribou Biosciences Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 55. CRISPR therapeutics Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 56. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 57. Horizon Discovery Plc Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 58. Sigma Aldrich Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 59. Genscript Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 60. Integrated DNA Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 61. New England Biolabs Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 62. Origene Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 63. Aldevron Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 64. Takara Bio Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global CRISPR Nucleases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CRISPR Cas3
Table 3. Key Players of CRISPR Cas9
Table 4. Key Players of CRISPR Cas10
Table 5. Key Players of Others
Table 6. Global CRISPR Nucleases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CRISPR Nucleases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CRISPR Nucleases Market Share by Region (2020-2025)
Table 10. Global CRISPR Nucleases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CRISPR Nucleases Market Share by Region (2026-2031)
Table 12. CRISPR Nucleases Market Trends
Table 13. CRISPR Nucleases Market Drivers
Table 14. CRISPR Nucleases Market Challenges
Table 15. CRISPR Nucleases Market Restraints
Table 16. Global CRISPR Nucleases Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CRISPR Nucleases Market Share by Players (2020-2025)
Table 18. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)
Table 19. Ranking of Global Top CRISPR Nucleases Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CRISPR Nucleases Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CRISPR Nucleases, Headquarters and Area Served
Table 22. Global Key Players of CRISPR Nucleases, Product and Application
Table 23. Global Key Players of CRISPR Nucleases, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CRISPR Nucleases Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CRISPR Nucleases Revenue Market Share by Type (2020-2025)
Table 27. Global CRISPR Nucleases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CRISPR Nucleases Revenue Market Share by Type (2026-2031)
Table 29. Global CRISPR Nucleases Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CRISPR Nucleases Revenue Market Share by Application (2020-2025)
Table 31. Global CRISPR Nucleases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CRISPR Nucleases Revenue Market Share by Application (2026-2031)
Table 33. North America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CRISPR Nucleases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CRISPR Nucleases Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CRISPR Nucleases Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CRISPR Nucleases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CRISPR Nucleases Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CRISPR Nucleases Market Size by Country (2026-2031) & (US$ Million)
Table 48. Thermo Fisher Company Details
Table 49. Thermo Fisher Business Overview
Table 50. Thermo Fisher CRISPR Nucleases Product
Table 51. Thermo Fisher Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 52. Thermo Fisher Recent Development
Table 53. TriLink BioTechnologies Company Details
Table 54. TriLink BioTechnologies Business Overview
Table 55. TriLink BioTechnologies CRISPR Nucleases Product
Table 56. TriLink BioTechnologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 57. TriLink BioTechnologies Recent Development
Table 58. Qiagen Company Details
Table 59. Qiagen Business Overview
Table 60. Qiagen CRISPR Nucleases Product
Table 61. Qiagen Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 62. Qiagen Recent Development
Table 63. Editas Medicine Company Details
Table 64. Editas Medicine Business Overview
Table 65. Editas Medicine CRISPR Nucleases Product
Table 66. Editas Medicine Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 67. Editas Medicine Recent Development
Table 68. Caribou Biosciences Company Details
Table 69. Caribou Biosciences Business Overview
Table 70. Caribou Biosciences CRISPR Nucleases Product
Table 71. Caribou Biosciences Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 72. Caribou Biosciences Recent Development
Table 73. CRISPR therapeutics Company Details
Table 74. CRISPR therapeutics Business Overview
Table 75. CRISPR therapeutics CRISPR Nucleases Product
Table 76. CRISPR therapeutics Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 77. CRISPR therapeutics Recent Development
Table 78. Intellia therapeutics, Inc. Company Details
Table 79. Intellia therapeutics, Inc. Business Overview
Table 80. Intellia therapeutics, Inc. CRISPR Nucleases Product
Table 81. Intellia therapeutics, Inc. Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 82. Intellia therapeutics, Inc. Recent Development
Table 83. Horizon Discovery Plc Company Details
Table 84. Horizon Discovery Plc Business Overview
Table 85. Horizon Discovery Plc CRISPR Nucleases Product
Table 86. Horizon Discovery Plc Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 87. Horizon Discovery Plc Recent Development
Table 88. Sigma Aldrich Company Details
Table 89. Sigma Aldrich Business Overview
Table 90. Sigma Aldrich CRISPR Nucleases Product
Table 91. Sigma Aldrich Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 92. Sigma Aldrich Recent Development
Table 93. Genscript Company Details
Table 94. Genscript Business Overview
Table 95. Genscript CRISPR Nucleases Product
Table 96. Genscript Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 97. Genscript Recent Development
Table 98. Integrated DNA Technologies Company Details
Table 99. Integrated DNA Technologies Business Overview
Table 100. Integrated DNA Technologies CRISPR Nucleases Product
Table 101. Integrated DNA Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 102. Integrated DNA Technologies Recent Development
Table 103. New England Biolabs Company Details
Table 104. New England Biolabs Business Overview
Table 105. New England Biolabs CRISPR Nucleases Product
Table 106. New England Biolabs Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 107. New England Biolabs Recent Development
Table 108. Origene Technologies Company Details
Table 109. Origene Technologies Business Overview
Table 110. Origene Technologies CRISPR Nucleases Product
Table 111. Origene Technologies Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 112. Origene Technologies Recent Development
Table 113. Aldevron Company Details
Table 114. Aldevron Business Overview
Table 115. Aldevron CRISPR Nucleases Product
Table 116. Aldevron Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 117. Aldevron Recent Development
Table 118. Takara Bio Company Details
Table 119. Takara Bio Business Overview
Table 120. Takara Bio CRISPR Nucleases Product
Table 121. Takara Bio Revenue in CRISPR Nucleases Business (2020-2025) & (US$ Million)
Table 122. Takara Bio Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. CRISPR Nucleases Picture
Figure 2. Global CRISPR Nucleases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR Nucleases Market Share by Type: 2024 VS 2031
Figure 4. CRISPR Cas3 Features
Figure 5. CRISPR Cas9 Features
Figure 6. CRISPR Cas10 Features
Figure 7. Others Features
Figure 8. Global CRISPR Nucleases Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CRISPR Nucleases Market Share by Application: 2024 VS 2031
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR Nucleases Report Years Considered
Figure 15. Global CRISPR Nucleases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CRISPR Nucleases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CRISPR Nucleases Market Share by Region: 2024 VS 2031
Figure 18. Global CRISPR Nucleases Market Share by Players in 2024
Figure 19. Global Top CRISPR Nucleases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Nucleases as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CRISPR Nucleases Revenue in 2024
Figure 21. North America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CRISPR Nucleases Market Share by Country (2020-2031)
Figure 23. United States CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CRISPR Nucleases Market Share by Country (2020-2031)
Figure 27. Germany CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CRISPR Nucleases Market Share by Region (2020-2031)
Figure 35. China CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CRISPR Nucleases Market Share by Country (2020-2031)
Figure 43. Mexico CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CRISPR Nucleases Market Share by Country (2020-2031)
Figure 47. Turkey CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CRISPR Nucleases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Thermo Fisher Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 51. TriLink BioTechnologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 52. Qiagen Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 53. Editas Medicine Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 54. Caribou Biosciences Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 55. CRISPR therapeutics Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 56. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 57. Horizon Discovery Plc Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 58. Sigma Aldrich Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 59. Genscript Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 60. Integrated DNA Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 61. New England Biolabs Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 62. Origene Technologies Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 63. Aldevron Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 64. Takara Bio Revenue Growth Rate in CRISPR Nucleases Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232